Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Gilead, Kite in process of pausing Twitter advertising
11:57am, Monday, 07'th Nov 2022
Gilead Sciences Inc said on Monday the company and its unit Kite were in the "process of pausing advertising" on Twitter, after Elon Musk completed his takeover of the social media company.
3 No-Brainer Dividend Stocks to Buy in November
09:31am, Saturday, 05'th Nov 2022
There's no need for agonizing decision-making with these great dividend stocks.
TEVA Misses on Q3 Earnings, Cuts 2022 Sales View, Stock Down
12:03pm, Friday, 04'th Nov 2022
TEVA reports dismal Q3 results, missing estimates for both earnings and sales. It slightly lowers its sales expectations for 2022 while keeping the adjusted earnings per share guidance intact.
Should I buy Gilead Sciences shares in November 2022?
04:32pm, Thursday, 03'rd Nov 2022
Gilead Sciences, Inc. (NASDAQ: GILD) shares have advanced from $61.45 to $80 since the beginning of October 2022, and the current price stands at $79.46. Gilead Sciences reported better-than-expected
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
10:33am, Monday, 31'st Oct 2022
Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.
Peak Gilead
08:01am, Monday, 31'st Oct 2022
Thursday 10/28/2022's Gilead earnings surprise to the upside was terribly sweet, after years of bitterness. Major revenue drivers were firing on all cylinders.
Gilead stock is not out of room to run just yet: Truist
05:13pm, Saturday, 29'th Oct 2022
Gilead Sciences Inc (NASDAQ: GILD) ended this week up nearly 20% after reporting its quarterly results that handily topped Street estimates and subsequently winning an upgrade from a Truist analyst. G
These 2 Stock Winners Topped Apple's Big Gains Friday
05:35pm, Friday, 28'th Oct 2022
Strong earnings helped lift the market.
Gilead Sciences stock surges amid earnings beat and analyst upgrades
04:43pm, Friday, 28'th Oct 2022
Shares of Gilead Sciences are getting a boost thanks to strong earnings for its third quarter.
Truist: Buy this undervalued biotech stock
02:21pm, Friday, 28'th Oct 2022
The "Halftime Report" traders debate the biggest analyst calls of the day
Gilead (GILD) Q3 Earnings & Sales Top, Guidance Raised
02:18pm, Friday, 28'th Oct 2022
Gilead (GILD) Q3 earnings and sales beat on strong HIV and oncology business. The company also raises its annual guidance.
Gilead Sciences, Inc. (GILD) Q3 2022 Earnings Call Transcript
08:33pm, Thursday, 27'th Oct 2022
Gilead Sciences, Inc. (NASDAQ:GILD ) Q3 2022 Results Conference Call October 27, 2022 4:30 PM ET Company Participants Jacquie Ross - VP, IR Daniel O'Day - Chairman and CEO Johanna Mercier - Chief Comm
Gilead Sciences (GILD) Q3 Earnings and Revenues Top Estimates
06:48pm, Thursday, 27'th Oct 2022
Gilead (GILD) delivered earnings and revenue surprises of 31.94% and 15.06%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Gilead Sciences Stock Climb After Q3 Earnings?
09:49pm, Wednesday, 26'th Oct 2022
Big Pharma will close out this week's earnings reports, with Gilead Sciences (GILD) set to give its Q3 results on October 27. With GILD edging towards its 52-week highs, investors will want to see if
Why Gilead (GILD) Could Beat Earnings Estimates Again
01:33pm, Wednesday, 26'th Oct 2022
Gilead (GILD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
